Neuromyelitisoptica is an inflammatory and demyelinating disease of the central nervous system that affects astrocytes in the optic nerve and the spinal cord. It is characterized by outbreaks of transverse myelitis and retro bulbar optic neuropathy with a pejorative aspect in terms of prognosis and prognosis in the short and medium term. We report the case of A S, 32 years old, male, Senegalese living in Dakar, hospitalized in June 2016 at the neurological clinic of the CHU of FANN, Dakar-Senegal for aneuromyelitisoptica. Magnetic resonance imaging showed cervical myelitis extended to the thoracic cord. The search for antibodies to aquaporin 4 was positive, the visual evoked potential showed P100 latency. Lumbar puncture performed, showed a protein content to 0.73 g/l and 10 elements (cells). The patient was placed under corticosteroid therapy. His clinical picture was stationary in the short term, with a recovery of the walk at 5 months of the appointment.
| Published in | Clinical Neurology and Neuroscience (Volume 1, Issue 2) |
| DOI | 10.11648/j.cnn.20170102.13 |
| Page(s) | 38-40 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2017. Published by Science Publishing Group |
Multiphasic, Neuromyelitis, Optica, Life-threatening
| [1] | Jarius and Wildemann. The history of neuromyelitisoptica. Journal of Neuroinflammation 2013, 10:8. |
| [2] | Masoud Etemadifar et al. Prevalence of NOM globally, 2015. |
| [3] | Sofiane Bourmatte, Assia Boulefkhad, Yamina Sifi, Naima Taghane, M’zahem Abderrahim, Abdelmadjid Hamri Neurologie, CHU de Constantine, Constantine, Algérie, Revue Nseurologie 172 S(2016) A5-A53. |
| [4] | Collogue N, Marignier R, Zephir H, et al. Neuromyelistisoptica in France; a multicenter study of 125 patients. Neurology, 2010: 736-42. |
| [5] | Wingerchuk DM et al, Revised diagnostic criteria for Neuro-myelitis optica. Neurology 2006; 66:1485-9. |
| [6] | Samy, Université Cheikh Anta Diop service de neurologie, Mémoire No 944, 2014. |
| [7] | J Seze, Stojkovic T, Ferriby D, et al. Devic’sneuromyelitisoptica: clinical, laboratory, MRI and outcome profile. JNeurolSci 2002; 197: 57-61. |
| [8] | Wingerchuck D, Hogancamp WF, O’Brien PC, Weinshenker B. The clinical course of neuromyelitisoptica (Devic’s syndrome). Neurology 1999; 53:1107-14. |
| [9] | Raphaël Bernard-Valnet, Romain Marignier, Évolution du spectre de la neuromyélite optique de Devic, Presse Med. 2015; 44: 401–410). |
| [10] | P. Cabre Épidémiologie descriptive de la neuromyélite optique dans le bassin caraïbéen - 16/09/09. |
| [11] | V. Déral-Stéphant, C. Roux-Lelièvre, R. Vignal, E. Stéphant, A. Faivre, P. Alla, Neuromyélite optique de Devic: discussion diagnostique après dix ans d’évolution d’une neuropathie optique bilatérale sévère, J Fr. Ophtalmol., 2008; 31, 7, 705-709) |
| [12] | Ghezzi A, Bergamaschi R, Martinelli V et al., clinical characteristics caurse and prognosis of relapsing Devic’s Neuromyélitisoptica. J Neurol 2004; 251: 47-52) |
| [13] | Marignier R, De Se`ze J, Vukusic S, Durand-Dubief F, Ze´phir H, Vermersch P, et al. NMO-IgG and Devic’sneuromyelitisoptica: a French experience. Mult Scler 2008;14:440–5. |
| [14] | Cabrera-Gomez JA, Saiz Hinarejos A, Graus F, et al., Brain magnetic resonance imaging findings in acute relapses of neurmyelitisoptica spectrum disorders. Mult sclera, 2008; 14: 248-51. |
APA Style
Patrice Ntenga, Salaheddine Mourabit, Soumaila Boubacar, Ousmane Cissé, Mouhamed Lelouma Mansare, et al. (2017). Multiphasic Neuromyelitis Optica and Life-threatening: A Case Repport. Clinical Neurology and Neuroscience, 1(2), 38-40. https://doi.org/10.11648/j.cnn.20170102.13
ACS Style
Patrice Ntenga; Salaheddine Mourabit; Soumaila Boubacar; Ousmane Cissé; Mouhamed Lelouma Mansare, et al. Multiphasic Neuromyelitis Optica and Life-threatening: A Case Repport. Clin. Neurol. Neurosci. 2017, 1(2), 38-40. doi: 10.11648/j.cnn.20170102.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cnn.20170102.13,
author = {Patrice Ntenga and Salaheddine Mourabit and Soumaila Boubacar and Ousmane Cissé and Mouhamed Lelouma Mansare and Kamadore Touré and Ndiaye Moustapha and Mouhamadou Mansour Ndiaye},
title = {Multiphasic Neuromyelitis Optica and Life-threatening: A Case Repport},
journal = {Clinical Neurology and Neuroscience},
volume = {1},
number = {2},
pages = {38-40},
doi = {10.11648/j.cnn.20170102.13},
url = {https://doi.org/10.11648/j.cnn.20170102.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cnn.20170102.13},
abstract = {Neuromyelitisoptica is an inflammatory and demyelinating disease of the central nervous system that affects astrocytes in the optic nerve and the spinal cord. It is characterized by outbreaks of transverse myelitis and retro bulbar optic neuropathy with a pejorative aspect in terms of prognosis and prognosis in the short and medium term. We report the case of A S, 32 years old, male, Senegalese living in Dakar, hospitalized in June 2016 at the neurological clinic of the CHU of FANN, Dakar-Senegal for aneuromyelitisoptica. Magnetic resonance imaging showed cervical myelitis extended to the thoracic cord. The search for antibodies to aquaporin 4 was positive, the visual evoked potential showed P100 latency. Lumbar puncture performed, showed a protein content to 0.73 g/l and 10 elements (cells). The patient was placed under corticosteroid therapy. His clinical picture was stationary in the short term, with a recovery of the walk at 5 months of the appointment.},
year = {2017}
}
TY - JOUR T1 - Multiphasic Neuromyelitis Optica and Life-threatening: A Case Repport AU - Patrice Ntenga AU - Salaheddine Mourabit AU - Soumaila Boubacar AU - Ousmane Cissé AU - Mouhamed Lelouma Mansare AU - Kamadore Touré AU - Ndiaye Moustapha AU - Mouhamadou Mansour Ndiaye Y1 - 2017/04/30 PY - 2017 N1 - https://doi.org/10.11648/j.cnn.20170102.13 DO - 10.11648/j.cnn.20170102.13 T2 - Clinical Neurology and Neuroscience JF - Clinical Neurology and Neuroscience JO - Clinical Neurology and Neuroscience SP - 38 EP - 40 PB - Science Publishing Group SN - 2578-8930 UR - https://doi.org/10.11648/j.cnn.20170102.13 AB - Neuromyelitisoptica is an inflammatory and demyelinating disease of the central nervous system that affects astrocytes in the optic nerve and the spinal cord. It is characterized by outbreaks of transverse myelitis and retro bulbar optic neuropathy with a pejorative aspect in terms of prognosis and prognosis in the short and medium term. We report the case of A S, 32 years old, male, Senegalese living in Dakar, hospitalized in June 2016 at the neurological clinic of the CHU of FANN, Dakar-Senegal for aneuromyelitisoptica. Magnetic resonance imaging showed cervical myelitis extended to the thoracic cord. The search for antibodies to aquaporin 4 was positive, the visual evoked potential showed P100 latency. Lumbar puncture performed, showed a protein content to 0.73 g/l and 10 elements (cells). The patient was placed under corticosteroid therapy. His clinical picture was stationary in the short term, with a recovery of the walk at 5 months of the appointment. VL - 1 IS - 2 ER -
Email: